FeesSafety
Pluang+

Aventis Energy confirms strong uranium radioactivity up to 48,000 cps at Saskatchewan's Corvo Project.

Market News
29 Oct 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
Aventis Energy confirms strong uranium radioactivity up to 48,000 cps at Saskatchewan's Corvo Project.

Aventis Energy's fall 2026 surface exploration at the Corvo Uranium Project in Saskatchewan revealed strong uranium radioactivity readings up to 48,000 cps, significantly higher than previous reports. The program identified new radioactive showings and confirmed favorable geology for uranium and rare earth elements. Assay results are pending, with plans for further geophysical surveys and a second drill program in 2027 to refine targets and advance exploration.

Aventis Energy's recent uranium exploration at Saskatchewan's Corvo Project provides context for readers following mining developments. For readers following Basic Materials stocks, here is Pluang's market snapshot as of Oct 29, 2026 17:51 WIB: Of 83 priced US stocks in the sector, 22 rose and 58 fell. Notable movers include CRH at USD 83.00 with a 1-day change of -4.09%, Endeavour Silver Corp (EXK) at USD 7.72 with a 1-day change of -3.14% and a Pluang order activity of 91% Sell / 9% Buy, and Sherwin-Williams Company (SHW) at USD 330.86 with a 1-day change of +3.14%.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App